Methods for diagnosing an increased risk for breast or ovarian c

Details Methods for diagnosing an increased risk for breast or ovarian c Methods for diagnosing an increased risk for breast or ovarian c

1996-04-12

1997-07-08

Jones, W. Gary

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

935 77, 935 78, C12Q 168, C12N 1500

Patent

active

056459955

ABSTRACT:
The present invention relates to methods for diagnosing an increased risk for breast or ovarian cancer by assaying for genetic markers in the human progesterone receptor gene.

REFERENCES:
patent: 4742000 (1988-05-01), Greene
patent: 5283190 (1994-02-01), Traish et al.
patent: 5364791 (1994-11-01), Vegeto et al.
Kieback et al. (1995) Anticancer Res. 15:1766-7.
Garrett et al, "Mendelian Inheritance of a TaqI Restriction Fragment Length Polymorphism Due to an Insertion in the Human PR Gene and Its Allelic Imbalance in Breast Cancer", Cancer Res., Therapy and Control, pp. 1-8 (1995).
Allgood et al, "Adaptation of a Novel Adenoviral Expression System to Study Function and Covalent Modification of Avian Progesterone Receptor", 76th Endocrine Society Meeting, Abst. No. 631 (1994).
Tong et al, "A TaqI RFLP in the Human Progesterone Receptor Gene (HPR) is Associated with Ovarian Cancer", ACR Meeting, 86th Annual Association for Cancer Research, (Preliminary Program), Totonto, Ontario, Canada, Abstract (March 18-22, 1995).
Levy et al, "Chicken Ovalbumin Upstream Promoter-- Transcription Factor (COUP-TF-like) Expression in Human Endometrial Cancer Cell Lines", 42nd Annual Society for Gynecologic Investigation, Chicago, Illinois, Abstract (Mar. 15-18, 1995).
Kieback et al, "A Genetic Mutation in the Human Progesterone Receptor Gene (HPR) is Associated with Ovarian Cancer", Society of Gynecological Oncologist, San Francisco, California, Marriott Hotel, 26th Annual Meeting, (Program in Brief), Abstract (Feb. 18-22, 1995).
Kieback et al, "A TaqI RFLP in the Human Progesterone Receptor Gene is Associated with Sporadic Epithelial Ovarian Cancer and with Breast Cancer", Society for Gynecologic Invesitgation, 42nd Annual Scientific Meeting (Postgraduate Courses), Chicago, Illinois, Abstract (Mar. 15-18, 1995).
Rowe et al, "The Ovarian Carcinoma-Associated TaqI Restriction Fragment Length Polymorphism in Intron G of the Progesterone Receptor Gene is Due to Alu Sequence Insertion", Cancer Research, 55:2743-2745 (1995).
Zhang et al, "Identification of a Group of Ser-Pro Motif Hormone-Inducible Phosphorylation Sites in the Human Progesterone Receptor", Mol. Endo., 9(8):1029-1040 (1995).
Fuqua et al, "Progesterone Receptor Gene Restriction Fragment Length Polymorphisms in Human Breast Tumors", J. Nat'l. Cancer Institute, 83(16):1157-1160 (1991).
Kieback et al, "Die Chemische Heteroduplexspaltung--Ein Verfahren Zur Entdeckung von Mutationen in Ostrogen-und Progesteronrezeptorgenen beim Mammakarzinom", Archives of Gynecology and Obstetrics, 250(1-4):249-250 (Sep. 11-15, 1990) (and English Translation).
McKenna et al, "A Germline TaqI Restriction Fragment Length Polymorphism in the Progesterone Receptor Gene in Ovarian Carcinoma", British J. of Cancer, 71:451-455 (1995).
Rodriguez et al, "Dimerization of the Chicken Progesterone Receptor In Vitro Can Occur in the Absence of Hormone and DNA", Molecular Endocrinology, 4(11):1782-1790 (1990).
Allan et al, "Ligand-Dependent Conformational Changes in the Progesterone Receptor are Necessary for Events that follow DNA Binding", Proc. Natl. Acad. Sci., USA, 89:11750-11754 (1992).
Allan et al, "Hormorne and Antihormone Induce Distinct Conformational Changes Which are Central to Steroid Receptor Activation", J. Biol. Chem., 267(27):19513--19520 (1992).
Sheridan et al, "Synthesis of Human Progesterone Receptors in T47D Cells", J. Biol. Chem., 264(12):7054-7058 (1989).
Tsai et al, "Molecular Mechanisms of Action of Steroid/Thyroid Receptor Superfamily Members", Ann. Rev. Biochem., 63:451-486 (1994).
Zhang et al, "Multiple Signaling Pat).hways Activate the Chicken Progesterone Receptor", Mol. Endo., 8(5):577-584 (1994).
Bai et al, "Phosphorylation of Ser.sup.530 Facilitates Hormone-Dependent Transcriptional Activation of the Chicken Progesterone Receptor", Mol. Endo., 8(11):1465-1473 (1994).
Agoulnik et al, "Genetic Mutations in the Human Progesterone Receptor Gene Associated with Increased Cancer Risk lead to a Structurally and Functionally Altered Receptor Protein", Proceedings, 87th Annual Meeting of the American Association Cancer Research, Washington, D.C., vol. 37, Abstract No. 1514 (Apr. 20-24, 1996).
Kieback et al, "A Complex of Mutations in the Human Progesterone Receptor Gene is Associated with Increased Risk of Non-familial Breast and Ovarian Cancer but not of Uterine Cancer", Proceedings, 87th Annual Meeting of the American Association Cancer Research, Washington, D.C., vol. 37, Abstsract No. 1704 (Apr. 20-24, 1996).

Affiliated with

Also associated with

Rating

Methods for diagnosing an increased risk for breast or ovarian c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for diagnosing an increased risk for breast or ovarian c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosing an increased risk for breast or ovarian c will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2408252